IGC Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.About IGC
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development.
IGC Key Statistics
Stock Snapshot
With a market cap of 27.15M, IGC Pharma(IGC) trades at $0.29. The stock has a price-to-earnings ratio of -3.71.
During the trading session on 2026-01-07, IGC Pharma(IGC) shares reached a daily high of $0.30 and a low of $0.29. At a current price of $0.29, the stock is +2.1% higher than the low and still -3.9% under the high.
Trading volume for IGC Pharma(IGC) stock has reached 454.64K, versus its average volume of 584.8K.
The stock's 52-week range extends from a low of $0.25 to a high of $0.50.
The stock's 52-week range extends from a low of $0.25 to a high of $0.50.
IGC News
IGC Pharma (IGC) announced that its Board of Directors has approved a change in the Company’s fiscal year end from March 31 to December 31, effective December 3...
IGC Pharma (IGC) entered into a Subscription Agreement with a group of investors for the purchase and sale of an aggregate of 779,997 shares of common stock in...
Claim 70% Off TipRanks This Holiday Season IGC Pharma ( (IGC) ) has provided an announcement. On December 30, 2025, IGC Pharma, Inc. announced that its Board...